Category Archives: Hypertension

Release Date: November 24, 2020 BUFFALO, N.Y. If youre sitting down, the findings of two major new studies led by University at Buffalo researchers are likely to get you moving. Women who met the federal physical activity guideline of 30 minutes per day of moderate activity exclusively through walking had a significantly lower risk of developing hypertension, according to a paper published in the November issue of the American Heart Association journal Hypertension Continue reading →

CALGARY -- Albertas government is now sharing data that shows how many people who have contracted COVID-19 have underlying conditions. But health experts, including Dr. Deena Hinshaw, say Albertans have to remember the virus is not just affecting people who are older or who are sick. Continue reading →

This article was originally published here Zhonghua Yi Xue Za Zhi. Continue reading →

The research report on Global Hypertension and Heart Failure Drugs Market is a professional detailing of the important elements that drive the Hypertension and Heart Failure Drugs market growth rate and revenue statistics. Continue reading →

Patients with end-stage renal disease (ESRD) have a cardiovascular mortality about 15-30 times the general population and this is reduced by about 70% with renal transplant. Dobutamine stress echocardiography (DSE) is commonly performed for preoperative cardiac evaluation before renal transplantation. Continue reading →

Medical practitioners have been told to consider choosing antihypertensive medications with the lowest possible potential for adverse drug effects such as sexual dysfunctions among adult hypertensive men in order to attain an optimum balance between antihypertensive efficacy and adequate preservation of sexual functions. Experts in an assessment of the effect of prescribed antihypertensive medications on sexual dysfunctions in men, including decreased libido and intercourse dissatisfaction, indicate that these drugs can cause medication-induced sexual dysfunctions but to various degrees. In a new study, the highest occurrence of sexual dysfunctions was associated with calcium-channel blockers in 32 (20.1 per cent) patients, followed by diuretics in 27 (17.0 per cent) and, angiotensin-converting enzyme inhibitors in 20 (12.6 per cent) patients. Continue reading →

An informative study on the Pulmonary Arterial Hypertension (PAH) Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by making business conclusions and shape the future of the organizations. Individual analysis of top regions and countries like North America, Europe, Asia-Pacific, South America, Asia-Pacific, Middle East & Africa and Latin America and the rest of the world is conducted. Industry overview, product definitions, and growth status are presented Continue reading →

November 26, 2020 12:50 ET | Source: insightSLICE PUNE, India, Nov. 26, 2020 (GLOBE NEWSWIRE) -- The Global Pharmacovigilance Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research & development activities, supply chain analysis, competitive landscape, and market composition analysis. The pharmacovigilance market size was estimated to be US$ 4.2 billion and is expected to reach US$ 18.7 billion by 2030 at a CAGR of 14.6% through 2030 Continue reading →

DUBLIN--(BUSINESS WIRE)--The "Acromegaly and Gigantism - Epidemiology Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. Continue reading →

A new research document with title Global Hypertension And Heart Failure Treatment Market Report covering detailed analysis, Competitive landscape, forecast and strategies has been added to the Insight Partners. The study covers geographic analysis that includes regions like North America, Europe and Asia-Pacific, South America, Middle East and Africa. The report will help user gain market insights, future trends and growth prospects for forecast to 2027. Continue reading →